# SPECTAmel: Screening Patients With Melanoma Tumors for Efficient Clinical Trial Access

> **NCT02507947** · — · WITHDRAWN · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC**

## Conditions studied

- Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02507947
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2030-01
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study closed
- **Last updated:** 2018-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02507947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02507947, "SPECTAmel: Screening Patients With Melanoma Tumors for Efficient Clinical Trial Access". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02507947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*